Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis

scientific article published on 01 September 1997

Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0016-5085(97)70186-0
P698PubMed publication ID9287983

P50authorHelmut FriessQ15453363
Markus BüchlerQ89169
P2093author name stringX Guo
L Gold
A Zimmermann
M Kashiwagi
M Korc
W H Tang
D Cantero
H Graber
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectplasminogenQ107129060
chronic pancreatitisQ1996053
P304page(s)904-913
P577publication date1997-09-01
P1433published inGastroenterologyQ4039279
P1476titleEnhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis
P478volume113

Reverse relations

cites work (P2860)
Q38182915A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix
Q37197386Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group
Q34909004Analysis of the human pancreatic stellate cell secreted proteome
Q53419924Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells.
Q36711064Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis
Q77983559Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis
Q28344075Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis
Q42468547Desmoplastic reaction influences pancreatic cancer growth behavior
Q91598075Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker
Q35361400Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis
Q73495088Expression of transforming growth factor-beta in spontaneous chronic pancreatitis in the WBN/Kob rat
Q74194859Galectin-1 and galectin-3 in chronic pancreatitis
Q35357077Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis
Q41871117Growth factor mediated signaling in pancreatic pathogenesis
Q73313355Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas
Q53243561High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma.
Q77457937Immunopathogenesis of chronic pancreatitis
Q73156216Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells
Q24800065Invasion and metastasis in pancreatic cancer
Q77598559KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma
Q77709638Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer
Q73181165Nerve growth factor and its high-affinity receptor in chronic pancreatitis
Q35130515Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice
Q57767952Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers
Q28141342TGF-beta: from latent to active
Q57768018The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings

Search more.